EP 1027054 A1 20000816 - LOCAL ADMINISTRATION OF PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION

Title (en)

LOCAL ADMINISTRATION OF PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION

Title (de)

LOKALE ANWENDUNG VON PHOSPHODIESTERASE INHIBITOREN ZUR BEHANDLUNG DER EREKTILEN DYSFUNKTION

Title (fr)

APPORT LOCAL D'INHIBITEURS DE PHOSPHODIESTERASES, DANS LE TRAITEMENT DU DYSFONCTIONNEMENT ERECTILE

Publication

EP 1027054 A1 20000816 (EN)

Application

EP 98954032 A 19981028

Priority

US 95881697 A 19971028
US 18107098 A 19981027
US 9822928 W 19981028

Abstract (en)

[origin: WO9921558A2] A method is provided for treating erectile dysfunction in a mammalian male individual. The method involves the local administration of a phosphodiesterase inhibitor or a pharmaceutically acceptable salt, ester, amide or derivative thereof, within the context of an effective dosing regimen. A preferred mode of administration is transurethral. Pharmaceutical formulations and kits are provided as well.

IPC 1-7

A61K 31/485; A61K 31/47; A61K 31/50; A61K 31/505

IPC 8 full level

A61K 9/02 (2006.01); A61K 31/00 (2006.01); A61K 31/343 (2006.01); A61K 31/381 (2006.01); A61K 31/4015 (2006.01); A61K 31/4164 (2006.01); A61K 31/4166 (2006.01); A61K 31/426 (2006.01); A61K 31/437 (2006.01); A61K 31/4439 (2006.01); A61K 31/444 (2006.01); A61K 31/47 (2006.01); A61K 31/4704 (2006.01); A61K 31/4709 (2006.01); A61K 31/4745 (2006.01); A61K 31/485 (2006.01); A61K 31/496 (2006.01); A61K 31/50 (2006.01); A61K 31/501 (2006.01); A61K 31/502 (2006.01); A61K 31/5025 (2006.01); A61K 31/517 (2006.01); A61K 31/519 (2006.01); A61K 31/52 (2006.01); A61K 31/522 (2006.01); A61K 31/5377 (2006.01); A61K 31/538 (2006.01); A61K 31/549 (2006.01); A61K 31/5513 (2006.01); A61K 45/00 (2006.01); A61K 45/06 (2006.01); A61P 15/10 (2006.01)

CPC (source: EP)

A61K 9/0034 (2013.01); A61K 31/00 (2013.01); A61K 31/343 (2013.01); A61K 31/381 (2013.01); A61K 31/4015 (2013.01); A61K 31/4164 (2013.01); A61K 31/4166 (2013.01); A61K 31/426 (2013.01); A61K 31/437 (2013.01); A61K 31/4439 (2013.01); A61K 31/444 (2013.01); A61K 31/4704 (2013.01); A61K 31/4709 (2013.01); A61K 31/4745 (2013.01); A61K 31/496 (2013.01); A61K 31/50 (2013.01); A61K 31/501 (2013.01); A61K 31/502 (2013.01); A61K 31/5025 (2013.01); A61K 31/519 (2013.01); A61K 31/52 (2013.01); A61K 31/522 (2013.01); A61K 31/538 (2013.01); A61K 31/549 (2013.01); A61K 31/5513 (2013.01); A61K 45/06 (2013.01); A61P 15/10 (2017.12)

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9921558 A2 19990506; WO 9921558 A3 20001026; AU 1125499 A 19990517; AU 734734 B2 20010621; CA 2305394 A1 19990506; CA 2305394 C 20061212; EP 1027054 A1 20000816; EP 1027054 A4 20021104; JP 2003525845 A 20030902

DOCDB simple family (application)

US 9822928 W 19981028; AU 1125499 A 19981028; CA 2305394 A 19981028; EP 98954032 A 19981028; JP 2000517716 A 19981028